ORPHA.CO Gross Margin

The Gross Margin of Orphazyme A/S (ORPHA.CO) is 7775.20%.

Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.

ORPHA.CO Gross Margin - Historical Value

Date	Value
2023-12-31	7775.20%

ORPHA.CO Gross Margin - Peers Comparison

Ticker	Name	Value
SCLP.L	Scancell Holdings PLC	90.13%
XBRANE.ST	Xbrane Biopharma AB	90.83%
XSPRAY.ST	XSpray Pharma AB (publ)	2539.90%
BIOPOR.CO	Bioporto A/S	67.68%
NANOV.OL	Nordic Nanovector ASA	7775.20%
SIGHT.PA	Gensight Biologics SA	188.37%
VVY.AS	Vivoryon Therapeutics NV	85.42%
ALBPS.PA	Biophytis SA	7775.20%
HPHA.DE	Heidelberg Pharma AG	74.01%
ORY.MC	Oryzon Genomics SA	-4700.00%
SANION.ST	Saniona AB	85.03%
TILS.L	Tiziana Life Sciences PLC	63.16%
FARN.L	Faron Pharmaceuticals Oy	95.19%
GLTO	Galecto Inc	7775.20%
IVACC.ST	Intervacc AB	-29.92%
NANO.PA	Nanobiotix SA	100.00%
POXEL.PA	Poxel SA	0.05%
BVXP.L	Bioventix PLC	93.20%
IVA.PA	Inventiva SA	146.31%
GMAB.CO	Genmab A/S	95.42%
BGBIO.OL	Bergenbio ASA	100.00%
CANTA.ST	Cantargia AB	7775.20%
DMYD B.ST	Diamyd Medical AB	-10161.54%
MAB.WA	Mabion SA	75.54%
SNG.L	Synairgen PLC	68.75%
ASND	Ascendis Pharma A/S	87.83%
BINV.ST	BioInvent International AB	42.37%
FLUO.ST	Fluoguide AS	7775.20%
IPH.PA	Innate Pharma SA	94.50%
OSE.PA	OSE Immunotherapeutics SA	100.00%
ZEAL.CO	Zealand Pharma A/S	87.44%
ALLR.ST	Allarity Therapeutics A/S	-175.91%
ALSEN.PA	Sensorion SA	7775.20%
BAVA.CO	Bavarian Nordic A/S	49.31%
SLN.L	Silence Therapeutics PLC	3133.78%
ABVX.PA	Abivax SA	-19700.00%